Chapter 1. ADVANCED CANCER DIAGNOSTICS MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. ADVANCED CANCER DIAGNOSTICS MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-110 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. ADVANCED CANCER DIAGNOSTICS MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. ADVANCED CANCER DIAGNOSTICS MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. ADVANCED CANCER DIAGNOSTICS MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. ADVANCED CANCER DIAGNOSTICS MARKET– By Technology
6.1. Imaging
6.2. Biopsy
6.3. Biomarkers
6.4. Others
Chapter 7. ADVANCED CANCER DIAGNOSTICS MARKET– By Application
7.1. Breast Cancer
7.2. Lung Cancer
7.3. Colorectal Cancer
7.4. Prostate Cancer
7.5. Skin Cancer
7.6. Others
Chapter 8. ADVANCED CANCER DIAGNOSTICS MARKET– By End-User
8.1. Hospitals
8.2. Diagnostic Laboratories
8.3. Cancer Research Institutes
Chapter 9. ADVANCED CANCER DIAGNOSTICS MARKET– By Region
9.1. North America
9.2. Europe
9.3. The Asia Pacific
9.4. Latin America
9.5. Middle-East and Africa
Chapter 10. ADVANCED CANCER DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Company 1
10.2. Company 2
10.3. Company 3
10.4. Company 4
10.5. Company 5
10.6. Company 6
10.7. Company 7
10.8. Company 8
10.9. Company 9
10.10. Company 10
2850
5250
4500
1800